This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n16http://localhost/temp/predkladatel/
n10http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n19http://linked.opendata.cz/ontology/domain/vavai/
n18http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n8http://bibframe.org/vocab/
n20http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F60162694%3AG44__%2F10%3A43874056%21RIV14-MO0-G44_____/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F60162694%3AG44__%2F10%3A43874056%21RIV14-MO0-G44_____
rdf:type
skos:Concept n19:Vysledek
rdfs:seeAlso
http://download.springer.com/static/pdf/385/art%253A10.1007%252Fs12032-009-9334-5.pdf?auth66=1397647473_cc3b3958eb555ea6ca64099c3a0f440a&ext=.pdf
dcterms:description
Tamoxifen is an orally active selective estrogen receptor modulator that is used in the treatment of breast cancer and is currently the world's largest selling drug for that purpose. However, it has some side effects including hot flashes, menstrual irregularity, vaginal discharges, uterine bleeding, uterine endometrial cancer, hypercoagulability, steatosis hepatis, risk of trombembolism. Long-term data from clinical trials have failed to demonstrate a cardioprotective effect and beneficial effects on serum lipid profiles. Arrhythmia secondary to tamoxifen is very rare. Tamoxifen is an orally active selective estrogen receptor modulator that is used in the treatment of breast cancer and is currently the world's largest selling drug for that purpose. However, it has some side effects including hot flashes, menstrual irregularity, vaginal discharges, uterine bleeding, uterine endometrial cancer, hypercoagulability, steatosis hepatis, risk of trombembolism. Long-term data from clinical trials have failed to demonstrate a cardioprotective effect and beneficial effects on serum lipid profiles. Arrhythmia secondary to tamoxifen is very rare.
dcterms:title
Tamoxifen and arryhythmia Tamoxifen and arryhythmia
skos:prefLabel
Tamoxifen and arryhythmia Tamoxifen and arryhythmia
skos:notation
RIV/60162694:G44__/10:43874056!RIV14-MO0-G44_____
n3:aktivita
n11:Z
n3:aktivity
Z(MO0FVZ0000503)
n3:cisloPeriodika
4
n3:dodaniDat
n9:2014
n3:domaciTvurceVysledku
n10:4798457
n3:druhVysledku
n7:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n20:predkladatel
n3:idSjednocenehoVysledku
291802
n3:idVysledku
RIV/60162694:G44__/10:43874056
n3:jazykVysledku
n4:eng
n3:klicovaSlova
Drug interaction; Arrhytmie; Tamoxifen
n3:klicoveSlovo
n5:Arrhytmie n5:Tamoxifen n5:Drug%20interaction
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[9CB209759951]
n3:nazevZdroje
Medical Oncology
n3:obor
n14:FD
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
4
n3:rokUplatneniVysledku
n9:2010
n3:svazekPeriodika
27
n3:tvurceVysledku
Priester, Peter Kopecký, Jindřich Petera, Jiří Slováček, Ladislav
n3:wos
000284547800067
n3:zamer
n18:MO0FVZ0000503
s:issn
1357-0560
s:numberOfPages
2
n8:doi
10.1007/s12032-009-9334-5
n16:organizacniJednotka
G44